CD8A and head and neck squamous cell carcinoma: On the other hand, Hanna et al. evaluated TILs in 42 actual ICI-treated virus-negative HNSCC patients with fresh specimens collected before ICI administration and reported that CD8+TIL levels were higher in responders compared to non-responders13.